Literature DB >> 12115620

Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.

Patricia Wilhelm1, D Sean Riminton, Uwe Ritter, Frances A Lemckert, Christina Scheidig, Robert Hoek, Jonathon D Sedgwick, Heinrich Körner.   

Abstract

Lymphotoxin (LT)alpha in combination with LTbeta forms membrane-bound heterotrimeric complexes with a crucial function in lymph node (LN) organogenesis and correct morphogenesis of secondary lymphoid tissue. To study the role of membrane LT (mLT) in lymphoid tissue organogenesis we generated an LTbeta-deficient mouse strain on a pure genetic C57BL/6 background (B6.LTbeta-/-) and compared it to a unique series of LTalpha-, TNF- and TNF/LTalpha-gene-targeted mice on an identical genetic background (B6.LTalpha-/-, B6.TNF-/- and B6 TNF/LTalpha-/-). B6.LTbeta-/- mice lacked peripheral LN with the exception of mesenteric LN, and displayed a disturbed micro-architecture of the spleen, although less profoundly than LTalpha- or TNF/LTalpha-deficient mice. Radiation bone marrow chimeras (B6.WT-->B6.LTbeta-/- developed Peyer's patch (PP)-like lymphoid aggregates in the intestinal wall indicating a possible role for soluble LTalpha(3) in the formation of the PP anlage. After infection with Leishmania major, B6.LTbeta-/- mice developed a fatal disseminating leishmaniasis resulting in death after 8 to 14 weeks, despite the natural resistance of the C57BL/6 genetic background (B6.WT) mice to the parasite. Both, the cellular and the humoral anti-L. major immune responses were delayed and ineffective. However, the expression pattern of the key cytokines IFN-gamma and IL-12 were comparable in B6.WT and B6.LTbeta-/- mice. Infection of radiation bone marrow chimeras showed that it is the LTbeta-dependent presence of lymphoid tissue and not the expression of mLT itself that renders mice resistant to leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115620     DOI: 10.1002/1521-4141(200207)32:7<1993::AID-IMMU1993>3.0.CO;2-F

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.

Authors:  Thomas W Spahn; Hans-Pietro Eugster; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction.

Authors:  Frances Vu; Umberto Dianzani; Carl F Ware; Tak Mak; Jennifer L Gommerman
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

Review 3.  LIGHT-related molecular network in the regulation of innate and adaptive immunity.

Authors:  Yanhui Xu; Koji Tamada; Lieping Chen
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

5.  Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.

Authors:  D R Roach; H Briscoe; B M Saunders; W J Britton
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice.

Authors:  Jan M Ehrchen; Johannes Roth; Kirsten Roebrock; Georg Varga; Wolfram Domschke; Rodney Newberry; Clemens Sorg; Carsten Müller-Tidow; Cord Sunderkötter; Torsten Kucharzik; Thomas W Spahn
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

7.  Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice.

Authors:  Dmitry V Kuprash; Marat B Alimzhanov; Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Ludmila N Drutskaya; Michael W Marino; Regina L Turetskaya; Arthur O Anderson; Klaus Rajewsky; Klaus Pfeffer; Sergei A Nedospasov
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

8.  TNF controls the infiltration of dendritic cells into the site of Leishmania major infection.

Authors:  Uwe Ritter; Anja Lechner; Katja Scharl; Ziba Kiafard; Jörg Zwirner; Heinrich Körner
Journal:  Med Microbiol Immunol       Date:  2007-07-28       Impact factor: 3.402

9.  Expression of lymphotoxin-alphabeta on antigen-specific T cells is required for DC function.

Authors:  Leslie E Summers-DeLuca; Douglas D McCarthy; Bojana Cosovic; Lesley A Ward; Calvin C Lo; Stefanie Scheu; Klaus Pfeffer; Jennifer L Gommerman
Journal:  J Exp Med       Date:  2007-04-23       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.